Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    UnavailableHealthcare: Gene Therapy Deals -- What Company Could Be Next?
    Currently unavailable

    Healthcare: Gene Therapy Deals -- What Company Could Be Next?

    FromIndustry Focus

    View podcast show
    Currently unavailable

    Healthcare: Gene Therapy Deals -- What Company Could Be Next?

    FromIndustry Focus

    ratings:
    Length:
    26 minutes
    Released:
    Mar 6, 2019
    Format:
    Podcast episode

    Description

    Here's why Roche's acquisition of gene therapy pioneer Spark Therapeutics and Biogen's acquisition of gene therapy upstart Nightstar Therapeutics could put Regenxbio in play. RHHBY, ONCE, BIIB, NITE, RGNX Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter
    Released:
    Mar 6, 2019
    Format:
    Podcast episode

    Titles in the series (100)

    Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.